Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Income from Non-Controlling Interests (2024 - 2026)

Usana Health Sciences (USNA) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with $180000.0 as the latest value for Q1 2026.

  • Quarterly Income from Non-Controlling Interests rose 500.0% to $180000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $717000.0 through Jan 2026, up 2290.0% year-over-year, with the annual reading at $717000.0 for FY2026, 2290.0% up from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 was $180000.0 at Usana Health Sciences, up from -$140000.0 in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $789000.0 in Q2 2025, with the low at -$140000.0 in Q3 2025.
  • Average Income from Non-Controlling Interests over 3 years is $149400.0, with a median of $30000.0 recorded in 2024.
  • Peak annual rise in Income from Non-Controlling Interests hit 500.0% in 2026, while the deepest fall reached 500.0% in 2026.
  • Over 3 years, Income from Non-Controlling Interests stood at $30000.0 in 2024, then tumbled by 566.67% to -$140000.0 in 2025, then soared by 228.57% to $180000.0 in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $180000.0, -$140000.0, and $789000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.